Published Online
on September 9, 2009

A more recent version of this article appeared on September 22, 2009

This Article Full Text (PDF) All Versions of this Article: 120/12/1024    most recent CIRCULATIONAHA.109.893362v2 CIRCULATIONAHA.109.893362v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Freedman, J. E. Articles by Gersh, B. J. PubMed PubMed Citation Articles by Freedman, J. E. Articles by Gersh, B. J. Related Collections Coagulation Other anticoagulants Embolic stroke Related Article

Submitted on ,
Accepted on ,

New Therapies for Stroke Prevention in Atrial Fibrillation. The Long Road to Enhanced Efficacy

Jane E. Freedman MD^* and Bernard J. Gersh MB, ChB, DPhil

From the Division of Cardiology, Boston University School of Medicine, Boston, Mass (J.E.F.), and Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn (B.J.G.).

^* To whom correspondence should be addressed. E-mail: freedmaj{at}bu.edu.

Key words: Editorials • anticoagulants • coagulation • fibrillation • stroke

Related Article:

The First Evaluation of a Novel Vitamin K Antagonist, Tecarfarin (ATI-5923), in Patients With Atrial Fibrillation

David J. Ellis, Mohammed Haris Usman, Peter G. Milner, Daniel M. Canafax, and Michael D. Ezekowitz
Circulation 2009 120: 1029-1035. [Abstract] [Full Text]